HCA Healthcare (NYSE:HCA – Get Free Report) had its target price reduced by stock analysts at Bank of America from $380.00 to $370.00 in a research note issued on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Bank of America‘s target price would indicate a potential upside of 12.67% from the company’s current price.
Other analysts have also recently issued reports about the stock. Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. Wells Fargo & Company downgraded HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their price objective for the company from $400.00 to $320.00 in a research report on Monday, November 25th. Royal Bank of Canada cut their price target on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday. JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 price objective on shares of HCA Healthcare in a research report on Tuesday, December 17th. Finally, TD Cowen lowered their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a report on Monday, October 28th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus target price of $382.19.
Read Our Latest Stock Report on HCA
HCA Healthcare Stock Performance
HCA Healthcare (NYSE:HCA – Get Free Report) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 520.98% and a net margin of 8.52%. During the same period last year, the business posted $5.90 EPS. As a group, research analysts forecast that HCA Healthcare will post 21.75 earnings per share for the current fiscal year.
Insider Activity
In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares in the company, valued at $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Phillip G. Billington sold 3,897 shares of the firm’s stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. This trade represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.70% of the stock is owned by corporate insiders.
Institutional Trading of HCA Healthcare
Hedge funds have recently made changes to their positions in the business. Legacy Investment Solutions LLC bought a new position in HCA Healthcare during the third quarter worth $39,000. Capital Performance Advisors LLP acquired a new position in HCA Healthcare in the 3rd quarter valued at about $41,000. Canoe Financial LP acquired a new position in shares of HCA Healthcare in the third quarter valued at approximately $41,000. Northwest Investment Counselors LLC bought a new stake in HCA Healthcare in the 3rd quarter valued at $44,000. Finally, Friedenthal Financial acquired a new stake in shares of HCA Healthcare during the third quarter worth $50,000. 62.73% of the stock is owned by institutional investors and hedge funds.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
See Also
- Five stocks we like better than HCA Healthcare
- Comparing and Trading High PE Ratio Stocks
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- What Does the Future Hold for Eli Lilly?
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.